Prescription Pain Medication Global Market Report 2025
상품코드:1760699
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
처방 진통제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 5.7%의 연평균 성장률로 972억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 맞춤형 의료에 대한 수요 증가, 외상 후 통증 관리에 대한 관심 증가, 통증 관리를 위한 원격의료 채택 확대, 오피오이드 대체 약물을 찾는 환자 증가, 신경병증성 통증의 유병률 증가 등의 요인이 성장을 견인할 것으로 예상됩니다. 이 시기의 주요 동향으로는 오피오이드 대체 진통제 개발, 디지털 헬스 솔루션의 통합, 표적 통증 치료의 혁신, 병용 진통제 개발, 비중독성 진통제의 발전 등을 꼽을 수 있습니다.
관절염의 유병률 증가는 처방 진통제 시장의 성장을 촉진할 것으로 예상됩니다. 관절염은 하나 이상의 관절에 염증을 일으켜 통증, 부종, 뻣뻣함, 강직, 운동 능력 저하를 유발하는 질환입니다. 관절염의 유병률 증가는 비만이 주요 원인이며, 과체중은 관절, 특히 무릎에 추가적인 부담을 주어 염증을 촉진하기 때문입니다. 처방 진통제는 염증과 통증을 줄이고 관절 기능을 개선하며 환자의 전반적인 삶의 질을 향상시킴으로써 관절염 관리에 도움을 줄 수 있습니다. 예를 들어, 2023년 3월 영국에 기반을 둔 정부 부서인 Office for Health Improvement and Disparities는 2022년 16세 이상 인구의 17.6%가 관절염 또는 진행 중인 허리 및 관절 문제를 가지고 있으며, 이는 2021년 17.0%에서 증가한 수치라고 보고했습니다. 그 결과, 관절염 유병률의 증가가 처방 진통제 시장의 성장을 주도하고 있습니다.
처방 진통제 시장의 기업들은 오피오이드 중독과 환자 안전에 대한 우려가 높아짐에 따라 비오피오이드 진통제와 같은 대체 요법 개발에 집중하고 있습니다. 비오피오이드 진통제는 오피오이드의 중독성 위험 없이 통증 완화를 제공하고 중독 및 과다복용 가능성을 낮추면서 보다 안전하고 효과적인 장기 통증 관리 솔루션을 제공합니다. 예를 들어, 2025년 1월 미국 생명공학 기업 버텍스 파마슈티컬스(Vertex Pharmaceuticals Inc.)는 미국 식품의약국(FDA)으로부터 최초의 비오피오이드 경구용 약물인 JOURNAVX에 대한 승인을 받았습니다. 이 약은 말초신경의 NaV1.8 나트륨 채널을 선택적으로 차단하여 중추신경계에 영향을 주지 않고 통증 신호를 억제함으로써 중독의 위험 없이 효과적인 급성 통증 완화를 제공합니다. 복부 성형술과 외반 모지 절제술을 대상으로 한 3상 임상시험에서 1일 2회 투여로 임상적으로 유의미한 통증 완화 효과를 보였으며, 규제 약물로 분류되지 않아 보다 안전한 급성 통증 관리의 필요성에 부응할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 처방 진통제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 처방 진통제 시장 : 성장률 분석
세계의 처방 진통제 시장 실적 : 규모와 성장, 2019-2024
세계의 처방 진통제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 처방 진통제 전체 시장(TAM)
제6장 시장 세분화
세계의 처방 진통제 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
처방전비스테로이드성 항염증제
오피오이드
항경련제
항우울제
기타 유형
세계의 처방 진통제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
주사제
경피
기타 투여 경로
세계의 처방 진통제 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
신경병증성 통증
암 통증
수술 후 통증
기타 용도
세계의 처방 진통제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 처방 진통제 시장, 처방비스테로이드성 항염증제, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
COX-2억제제
기존 비스테로이드성 항염증제
비스테로이드성 항염증제 병용
세계의 처방 진통제 시장, 오피오이드, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
강력한 오피오이드
경도 오피오이드
오피오이드 복합제
세계의 처방 진통제 시장, 항경련제, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
나트륨 채널 차단제
감마 아미노 부티르산 모듈레이터
글루탐산 억제제
세계의 처방 진통제 시장, 항우울제, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
선택적 세로토닌 재흡수 억제제
삼환계 항우울제
세로토닌·노르에피네프린 재흡수 억제제
기타 항우울제
세계의 처방 진통제 시장, 기타 유형, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
근이완제
국소 진통제
코르티코스테로이드
제7장 지역별·국가별 분석
세계의 처방 진통제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 처방 진통제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
처방 진통제 시장 : 경쟁 구도
처방 진통제 시장 : 기업 개요
Mallinckrodt Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Bayer AG
Sanofi S.A.
Bristol-Myers Squibb Company
AstraZeneca plc
Novartis International AG
GlaxoSmithKline Public Limited Company
Takeda Pharmaceutical Company Limited
Eli Lilly And Company
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Mylan N.V.
Sandoz, Inc
Bausch Health Companies Inc.
Purdue Pharma L.P.
Endo International Plc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
처방 진통제 시장 2029 : 새로운 기회를 제공하는 국가
처방 진통제 시장 2029 : 새로운 기회를 제공하는 부문
처방 진통제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare provider to manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when pain cannot be sufficiently controlled with non-prescription options.
The main types of prescription pain medications include prescription non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-epileptic medications, antidepressants, and other types. Prescription NSAIDs are medications prescribed by healthcare professionals to reduce inflammation, relieve pain, and lower fever by inhibiting cyclooxygenase (COX) enzymes. These medications can be administered through various routes, such as oral, injectable, transdermal, and others. They are used to treat a wide range of conditions, including neuropathic pain, cancer pain, post-operative pain, and more. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The prescription pain medications market research report is one of a series of new reports from The Business Research Company that provides prescription pain medications market statistics, including the prescription pain medications industry's global market size, regional shares, competitors with the prescription pain medications market share, detailed prescription pain medications market segments, market trends and opportunities, and any further data you may need to thrive in the prescription pain medications market. This prescription pain medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The prescription pain medication market size has grown strongly in recent years. It will grow from $73.59 billion in 2024 to $77.97 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to factors such as the increasing prevalence of chronic pain, a rising number of surgical procedures, a growing focus on palliative care, and an increase in musculoskeletal disorders.
The prescription pain medication market size is expected to see strong growth in the next few years. It will grow to $97.23 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. In the forecast period, growth is expected to be driven by factors such as the increasing demand for personalized medicine, a growing focus on post-traumatic pain management, greater adoption of telemedicine for pain management, a rising number of patients seeking opioid alternatives, and an increasing prevalence of neuropathic pain. Key trends during this period include the development of non-opioid pain alternatives, the integration of digital health solutions, innovation in targeted pain therapies, the development of combination pain medications, and advancements in non-addictive pain medications.
The growing prevalence of arthritis is expected to drive the expansion of the prescription pain medication market. Arthritis, which causes inflammation in one or more joints, leads to pain, swelling, stiffness, and reduced mobility. The rising prevalence of arthritis is largely attributed to obesity, as excess weight places additional stress on joints, especially the knees, and promotes inflammation. Prescription pain medications help manage arthritis by reducing inflammation and pain, improving joint function, and enhancing the overall quality of life for those affected. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2022, 17.6% of people aged 16 and older had arthritis or an ongoing back or joint problem, up from 17.0% in 2021. As a result, the increasing prevalence of arthritis is driving growth in the prescription pain medication market.
Companies in the prescription pain medication market are focusing on developing alternative therapies, such as non-opioid painkillers, in response to growing concerns about opioid addiction and patient safety. Non-opioid painkillers provide pain relief without the addictive risks of opioids, offering safer and more effective long-term pain management solutions while reducing the potential for addiction and overdose. For instance, in January 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for JOURNAVX, a first-in-class non-opioid oral medication. This medication selectively blocks NaV1.8 sodium channels in peripheral nerves to inhibit pain signals without affecting the central nervous system, offering effective acute pain relief without the risk of addiction. It has shown clinically meaningful pain reduction in Phase 3 trials for abdominoplasty and bunionectomy with a twice-daily dosing regimen, and it is not classified as a controlled substance, addressing the need for safer acute pain management.
In October 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Biohaven Pharmaceuticals for $11.6 billion. This acquisition allows Pfizer to strengthen and expand its migraine treatment portfolio, accelerate the commercialization of innovative therapies, and enhance its internal medicine pipeline for sustained growth. Biohaven Pharmaceuticals, a US-based biopharmaceutical company, manufactures prescription pain medications.
Major players in the prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz, Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc.
North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prescription pain medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the prescription pain medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The prescription pain medication market consists of sales of acetaminophen, antidepressants, anticonvulsants, muscle relaxants, and biologic pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prescription Pain Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prescription pain medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prescription pain medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription pain medication market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs; Opioids; Anti-Epileptic Medicines; Antidepressants; Other Types
2) By Route Of Administration: Oral; Injectable; Transdermal; Other Route Of Administrations
3) By Application: Neuropathic Pain; Cancer Pain; Post-Operative Pain; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors; Traditional Non-Steroidal Anti-Inflammatory Drugs; Combination Non-Steroidal Anti-Inflammatory Drugs
2) By Opioids: Strong Opioids; Mild Opioids; Opioid Combination Medications
3. Prescription Pain Medication Market Trends And Strategies
4. Prescription Pain Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Prescription Pain Medication Growth Analysis And Strategic Analysis Framework
5.1. Global Prescription Pain Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prescription Pain Medication Market Growth Rate Analysis
5.4. Global Prescription Pain Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prescription Pain Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prescription Pain Medication Total Addressable Market (TAM)
6.2. Global Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Transdermal
Other Route Of Administrations
6.3. Global Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuropathic Pain
Cancer Pain
Post-Operative Pain
Other Applications
6.4. Global Prescription Pain Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Prescription Pain Medication Market, Sub-Segmentation Of Prescription Non-Steroidal Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
COX-2 Inhibitors
Traditional Non-Steroidal Anti-Inflammatory Drugs
Combination Non-Steroidal Anti-Inflammatory Drugs
6.6. Global Prescription Pain Medication Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strong Opioids
Mild Opioids
Opioid Combination Medications
6.7. Global Prescription Pain Medication Market, Sub-Segmentation Of Anti-Epileptic Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sodium Channel Blockers
Gamma-Aminobutyric Acid Modulators
Glutamate Inhibitors
6.8. Global Prescription Pain Medication Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Serotonin Reuptake Inhibitors
Tricyclic Antidepressants
Serotonin-Norepinephrine Reuptake Inhibitors
Other Antidepressants
6.9. Global Prescription Pain Medication Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Muscle Relaxants
Topical Pain Medications
Corticosteroids
7. Prescription Pain Medication Market Regional And Country Analysis
7.1. Global Prescription Pain Medication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prescription Pain Medication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prescription Pain Medication Market
9.1. China Prescription Pain Medication Market Overview
9.2. China Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prescription Pain Medication Market
10.1. India Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prescription Pain Medication Market
11.1. Japan Prescription Pain Medication Market Overview
11.2. Japan Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prescription Pain Medication Market
12.1. Australia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prescription Pain Medication Market
13.1. Indonesia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prescription Pain Medication Market
14.1. South Korea Prescription Pain Medication Market Overview
14.2. South Korea Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prescription Pain Medication Market
15.1. Western Europe Prescription Pain Medication Market Overview
15.2. Western Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prescription Pain Medication Market
16.1. UK Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Prescription Pain Medication Market
17.1. Germany Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prescription Pain Medication Market
18.1. France Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Prescription Pain Medication Market
19.1. Italy Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Prescription Pain Medication Market
20.1. Spain Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prescription Pain Medication Market
21.1. Eastern Europe Prescription Pain Medication Market Overview
21.2. Eastern Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prescription Pain Medication Market
22.1. Russia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prescription Pain Medication Market
23.1. North America Prescription Pain Medication Market Overview
23.2. North America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prescription Pain Medication Market
24.1. USA Prescription Pain Medication Market Overview
24.2. USA Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prescription Pain Medication Market
26.1. South America Prescription Pain Medication Market Overview
26.2. South America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prescription Pain Medication Market
27.1. Brazil Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prescription Pain Medication Market
28.1. Middle East Prescription Pain Medication Market Overview
28.2. Middle East Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prescription Pain Medication Market
29.1. Africa Prescription Pain Medication Market Overview
29.2. Africa Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prescription Pain Medication Market Competitive Landscape And Company Profiles
